Filing Flows

Filing Flows › Privia Health Group (PRVA) › Takeover & LBO

Is Privia Health Group (PRVA) a takeover target?

A leveraged buyout does not work for Privia Health Group on its latest figures: its EBITDA margin is only 2.6% ($63.8M on revenue of $2.4B), too thin to carry buyout debt.

Share price$21.48
Market value$2.9B
Enterprise value$2.5B
Cash$446M
Debt$0
Revenue, 12 months$2.4B
Revenue growth+19%
EBITDA, 12 months$63.8M

Why a leveraged buyout does not fit

Privia Health Group kept 2.6% of its revenue as EBITDA over the last 12 months ($63.8M on $2.4B). A margin that thin cannot carry the debt a leveraged buyout needs — a small dip in sales would leave nothing for interest — so the model gives no buyout price.

What a takeover could cost

Takeovers in its sector paid a median premium of 35% over the share price before the deal (the middle half 22% to 45%), according to the 15 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, Privia Health Group would cost about $29.00 a share, $3.8B for all its shares.

Premium%Price a shareAll shares
Low end (a quarter of deals paid less)22%$26.21$3.5B
Median35%$29.00$3.8B
High end (a quarter paid more)45%$31.15$4.1B

Privia Health Group's latest quarter

Privia Health Group, Q3 2026: revenue $657M (+13% year over year), operating margin 3.1%, net earnings $13.5M, operating cash flow $28.9M. The chart follows the revenue to costs, profit and cash.

Questions

Is Privia Health Group being acquired?

No headline, 8-K or 13D about a sale is on file in the last year.

Could private equity buy Privia Health Group?

A leveraged buyout does not work for Privia Health Group on its latest figures: its EBITDA margin is only 2.6% ($63.8M on revenue of $2.4B), too thin to carry buyout debt. A margin that thin leaves almost nothing to pay interest with, so buyout debt does not fit.

What would a takeover of Privia Health Group cost?

Takeovers in its sector paid a median premium of 35% over the share price before the deal (the middle half 22% to 45%), according to the 15 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, Privia Health Group would cost about $29.00 a share, $3.8B for all its shares.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.